Peripheral blood cell staining showed that treatment with entinostat alone and in combination with SurVaxM reduced Foxp3 level in Tregs of tumor-bearing mice (Fig. 3C), but had no effect on Tregs number (data not shown). This evidence concerns the gene FOXP3 and neoplasm.